Predictors of Loss to Follow-Up After Engagement in Care of HIV-Infected Children Ineligible for Antiretroviral Therapy in an HIV Cohort Study in India
Abstract
Introduction
Methods
Setting and Design
Definitions
Statistical Analysis and Ethics Statement
Results
Discussion
Conclusion
Authors’ Contributions
Acknowledgments
Conflicts of interest
References
- UNAIDS. 2012 UNAIDS Report on the Global AIDS Epidemic. Available online: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_U NAIDS_Global_Report_2012_en.pdf (accessed on 5 December 2012).
- Spira, R.; Lepage, P.; Msellati, P.; et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics. 1999, 104, e56. [Google Scholar] [CrossRef]
- Newell, M.L.; Coovadia, H.; Cortina-Borja, M.; et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004, 364, 1236–43. [Google Scholar] [CrossRef]
- Edmonds, A.; Yotebieng, M.; Lusiama, J.; et al. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med. 2011, 8, e1001044. [Google Scholar] [CrossRef]
- Fox, M.P.; Larson, B.; Rosen, S. Defining retention and attrition in pre-antiretroviral HIV care: proposals based on experience in Africa. Trop Med Int Health. 2012, 17, 1235–44. [Google Scholar] [CrossRef]
- Alvarez-Uria, G.; Naik, P.K.; Midde, M.; Pakam, R. Predictors of delayed entry into medical care of children diagnosed with HIV infection: data from an HIV cohort study in India. ScientificWorldJournal. 2013, 2013, 737620. [Google Scholar] [CrossRef] [PubMed]
- National AIDS Control Organisation. Guidelines for HIV Care and Treatment in Infants and Children. Accessed on: July 31, 2013. Available at: http://www.nacoonline.org/NACO/About_NACO/Pol icy Guidelines/Policies Guidelines1/.
- Mugglin, C.; Estill, J.; Wandeler, G.; et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health. 2012, 17, 1509–20. [Google Scholar] [CrossRef]
- Alvarez-Uria, G.; Midde, M.; Pakam, R.; Naik, P.K. Predictors of attrition in patients ineligible for antiretroviral therapy after being diagnosed with HIV: data from an HIV cohort study in India. Biomed Res Int. 2013, 2013, 858023. [Google Scholar] [CrossRef] [PubMed]
- Alvarez-Uria, G.; Pakam, R.; Midde, M.; Naik, P.K. Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries. Interdiscip Perspect Infect Dis. 2013, 2013, 384805. [Google Scholar] [CrossRef] [PubMed]
- Mugglin, C.; Wandeler, G.; Estill, J.; et al. Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review. PLoS One. 2013, 8, e56446. [Google Scholar] [CrossRef]
- National AIDS Control Organisation. India. HIV estimates 2012. Technical report. Accessed on: July 22, 2013. Available at: www.nacoonline.org/upload/Surveillance/Reports%20 &%20Publication/Technical%20Report%20-%20India%20HIV%20Estimates%202012.pdf.
- Alvarez-Uria, G.; Midde, M.; Pakam, R.; Kannan, S.; Bachu, L.; Naik, P.K. Factors Associated with Late Presentation of HIV and Estimation of Antiretroviral Treatment Need according to CD4 Lymphocyte Count in a Resource-Limited Setting: Data from an HIV Cohort Study in India. Interdiscip Perspect Infect Dis. 2012, 2012, 293795. [Google Scholar] [CrossRef]
- Alvarez-Uria, G.; Midde, M.; Pakam, R.; Naik, P.K. Gender differences, routes of transmission, socio-demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India. Infect Dis Rep. 2012, 4, e19. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Accessed on July 10, 2013. Available at: http://www.who.int/hiv/pub/paediatric/infants2010/e n/index.html.
- HIV Paediatric Prognostic Markers Collaborative Study, Boyd K, Dunn DT, et al. Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children. AIDS. 2010, 24, 1213–7. [Google Scholar]
- HIV Paediatric Prognostic Markers Collaborative Study. Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1-infected children. AIDS. 2006, 20, 1289–94. [Google Scholar] [CrossRef]
- Estimating risk of disease progression in HIV-infected children. Accessed on August 11, 2013. Available at: http://www.hppmcs.org/.
- Alvarez-Uria, G.; Midde, M.; Naik, P.K. Socio-demographic risk factors associated with HIV infection in patients seeking medical advice in a rural hospital of India. J Public health Res. 2012, 1, e14. [Google Scholar] [CrossRef]
- Chi, B.H.; Yiannoutsos, C.T.; Westfall, A.O.; et al. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med. 2011, 8, e1001111. [Google Scholar] [CrossRef]
- Fine, J.P.; Gray, R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999, 94, 496–509. [Google Scholar] [CrossRef]
- Buchholz, B.; Hien, S.; Weichert, S.; Tenenbaum, T. Pediatric aspects of HIV1-infection--an overview. Minerva Pediatr. 2010, 62, 371–87. [Google Scholar]
- Lessells, R.J.; Mutevedzi, P.C.; Cooke, G.S.; Newell, M.L. Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2011, 56, e79–e86. [Google Scholar] [CrossRef]
- Larson, B.A.; Brennan, A.; McNamara, L.; et al. Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Trop Med Int Health. 2010, 15 Suppl 1, 43–7. [Google Scholar] [CrossRef] [PubMed]
- Wachira, J.; Middlestadt, S.E.; Vreeman, R.; Braitstein, P. Factors underlying taking a child to HIV care: implications for reducing loss to follow-up among HIV- infected and -exposed children. SAHARA J. 2012, 9, 20–9. [Google Scholar] [CrossRef] [PubMed]
- Dhillon, P.K.; Jeemon, P.; Arora, N.K.; et al. Status of epidemiology in the WHO South-East Asia region: burden of disease, determinants of health and epidemiological research, workforce and training capacity. Int J Epidemiol. 2012, 41, 847–60. [Google Scholar] [CrossRef] [PubMed]
- WFP United Nations World Food Programme - Fighting Hunger Worldwide. HIV, AIDS, TB and Nutrition. Accessed on January 21, 2014. Available at: http://www.wfp.org/content/hiv-aids-tb-and-nutrition.
- Brinkhof, M.W.G.; Pujades-Rodriguez, M.; Egger, M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009, 4, e5790. [Google Scholar] [CrossRef] [PubMed]

| N (%) | SHR (95% CI) | aSHR (95% CI) | |
|---|---|---|---|
| Age (years) | |||
| 0-1 | 27 (9.57) | 0.23 (0.03-1.72) | 0.54 (0.04-7.97) |
| 2-4 | 102 (36.17) | 0.80 (0.39-1.63) | 1.66 (0.46-6.06) |
| 5-9 | 117 (41.49) | 1 (Reference) | 1 (Reference) |
| 10-14 | 36 (12.77) | 0.50 (0.15-1.67) | 0.12* (0.03-0.55) |
| Gender | |||
| Female | 148 (52.48) | 1.01 (0.52-1.94) | 1.15 (0.56-2.39) |
| Male | 134 (47.52) | 1 (Reference) | 1 (Reference) |
| Community | |||
| OC | 58 (20.57) | 1.16 (0.48-2.82) | 0.96 (0.35-2.65) |
| BC | 145 (51.42) | 1 (Reference) | 1 (Reference) |
| SC | 63 (22.34) | 1.69 (0.75-3.81) | 1.31 (0.50-3.43) |
| ST | 16 (5.67) | 2.37 (0.85-6.56) | 2.36 (0.77-7.18) |
| Living near a town | |||
| No | 178 (63.12) | 1 (Reference) | 1 (Reference) |
| Yes | 104 (36.88) | 0.94 (0.48-1.84) | 0.89 (0.40-1.98) |
| Time to the clinics | |||
| ≤30 min | 79 (28.01) | 1 (Reference) | 1 (Reference) |
| >30 min | 203 (71.99) | 2.00 (0.82-4.85) | 2.09 (0.73-5.96) |
| Year of enrolment | |||
| 2007 | 44 (15.6) | 1 (Reference) | 1 (Reference) |
| 2008 | 57 (20.21) | 0.78 (0.20-3.06) | 0.58 (0.14-2.44) |
| 2009 | 63 (22.34) | 1.64 (0.52-5.18) | 1.30 (0.36-4.69) |
| 2010 | 55 (19.5) | 2.03 (0.65-6.28) | 2.05 (0.62-6.76) |
| 2011 | 32 (11.35) | 2.05 (0.58-7.31) | 2.02 (0.51-8.00) |
| 2012 | 31 (10.99) | 3.07 (0.84-11.16) | 3.48 (0.97-12.51) |
| Status of parents | |||
| Alive, rented house | 81 (28.72) | 1 (Reference) | 1 (Reference) |
| Alive, owned house | 68 (24.11) | 0.84 (0.35-1.99) | 0.64 (0.24-1.69) |
| Father died | 71 (25.18) | 0.56 (0.22-1.39) | 0.26* (0.09-0.75) |
| Mother died | 32 (11.35) | 0.74 (0.25-2.26) | 0.51 (0.15-1.79) |
| Both died | 30 (10.64) | 0.59 (0.18-1.96) | 0.47 (0.14-1.57) |
| 12-month AIDS risk | |||
| <3% | 67 (23.76) | 3.02* (1.09-8.39) | 10.77* (1.93-60.07) |
| 3-3.4% | 117 (41.49) | 1.59 (0.56-4.50) | 1.34 (0.33-5.48) |
| 3.5-3.9% | 27 (9.57) | 2.36 (0.60-9.20) | 1.65 (0.33-8.28) |
| ≥4% | 71 (25.18) | 1 (Reference) | 1 (Reference) |
© GERMS 2014.
Share and Cite
Alvarez-Uria, G.; Naik, P.K.; Midde, M.; Pakam, R. Predictors of Loss to Follow-Up After Engagement in Care of HIV-Infected Children Ineligible for Antiretroviral Therapy in an HIV Cohort Study in India. GERMS 2014, 4, 9-15. https://doi.org/10.11599/germs.2014.1049
Alvarez-Uria G, Naik PK, Midde M, Pakam R. Predictors of Loss to Follow-Up After Engagement in Care of HIV-Infected Children Ineligible for Antiretroviral Therapy in an HIV Cohort Study in India. GERMS. 2014; 4(1):9-15. https://doi.org/10.11599/germs.2014.1049
Chicago/Turabian StyleAlvarez-Uria, Gerardo, Praveen Kumar Naik, Manoranjan Midde, and Raghavakalyan Pakam. 2014. "Predictors of Loss to Follow-Up After Engagement in Care of HIV-Infected Children Ineligible for Antiretroviral Therapy in an HIV Cohort Study in India" GERMS 4, no. 1: 9-15. https://doi.org/10.11599/germs.2014.1049
APA StyleAlvarez-Uria, G., Naik, P. K., Midde, M., & Pakam, R. (2014). Predictors of Loss to Follow-Up After Engagement in Care of HIV-Infected Children Ineligible for Antiretroviral Therapy in an HIV Cohort Study in India. GERMS, 4(1), 9-15. https://doi.org/10.11599/germs.2014.1049
